Internal Medicine & Subspecialties
21st Annual Nicotine Dependence Conference
April 14 -
2014 - Mayo Clinic, Rochester, MN
- Hurt, Richard D., M.D.
- Stevens, Sheila K.
Upon conclusion of this program, participants should be able to:
- Describe the benefits of off-label dosing of Food and Drug Administration-approved pharmacotherapy, including combination therapy and high-dose nicotine replacement therapy
- Translate the concepts of addiction, pharmacotherapy, cognitive-behavioral therapy and relapse prevention into the provision of treatment
Attendance at this Mayo course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.